Syndax Pharmaceuticals, Inc. (SNDX)
9.40
-0.14
(-1.47%)
USD |
NASDAQ |
Nov 13, 10:51
Syndax Pharmaceuticals Net Income (Annual) : -285.42M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -285.42M |
| December 31, 2024 | -318.76M |
| December 31, 2023 | -209.36M |
| December 31, 2022 | -149.34M |
| December 31, 2021 | 24.93M |
| December 31, 2020 | -77.06M |
| December 31, 2019 | -56.05M |
| December 31, 2018 | -73.96M |
| Date | Value |
|---|---|
| December 31, 2017 | -60.80M |
| December 31, 2016 | -44.47M |
| December 31, 2015 | -24.12M |
| December 31, 2014 | -19.83M |
| December 31, 2013 | -60.45M |
| December 31, 2012 | -9.965M |
| December 31, 2011 | -13.09M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Emergent BioSolutions, Inc. | 52.60M |
| Incyte Corp. | 1.287B |
| Vertex Pharmaceuticals, Inc. | 3.953B |
| Travere Therapeutics, Inc. | -50.26M |